Since 2018 I have been working as an internist oncologist at the Antoni van Leeuwenhoek and the Netherlands Cancer Institute where I conduct research as a group leader in the field of sarcomas and Adolescents and Young adults (“AYA”). In my work as an internist oncologist I focus on the drug treatment of patients with sarcomas, GIST and desmoid (fibromatosis).

I also see people, who are often already cancer patients themselves, who have a hereditary predisposition to getting cancer through a germline TP 53 mutation (the so-called Li Fraumeni Syndrome). The AVL is the central place in the Netherlands for screening these risk families.